China’s Sinovac offers inadequate protection against Omicron, study shows

China’s Sinovac offers inadequate protection against Omicron, study shows

FT.com

Published

Hong Kong researchers say two doses of the jab provided ‘insufficient’ antibodies against new variant

Full Article